Evaluation and Management of Nonculprit Lesions in STEMI.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
25 05 2020
Historique:
received: 30 10 2019
revised: 18 02 2020
accepted: 25 02 2020
entrez: 23 5 2020
pubmed: 23 5 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

Identifiants

pubmed: 32438985
pii: S1936-8798(20)30632-4
doi: 10.1016/j.jcin.2020.02.030
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1145-1154

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Troels Thim (T)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: troels.thim@clin.au.dk.

Nina W van der Hoeven (NW)

Department of Cardiology, Amsterdam UMC, Amsterdam, the Netherlands.

Carmine Musto (C)

Department of Interventional Cardiology, San Camillo Hospital, Rome, Italy.

Robin Nijveldt (R)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Matthias Götberg (M)

Department of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.

Thomas Engstrøm (T)

Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Pieter C Smits (PC)

Department of Cardiology, Maasstad Ziekenhuis, Rotterdam, the Netherlands.

Keith G Oldroyd (KG)

Department of Cardiology, Golden Jubilee National Hospital, Glasgow, United Kingdom.

Anthony H Gershlick (AH)

University of Leicester, University Hospitals of Leicester, Leicester Biomedical Research Unit, Leicester, United Kingdom.

Javier Escaned (J)

Hospital Clinico San Carlos IDISSC, Complutense University, Madrid, Spain.

Sergio Bravo Baptista (SB)

University Clinic of Cardiology, Faculty of Medicine at University of Lisbon, Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal.

Luis Raposo (L)

Cardiology Department, Santa Cruz Hospital-CHLO, Lisbon, Portugal.

Niels van Royen (N)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Michael Maeng (M)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH